XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:    
Research and development $ 90,621,570 $ 35,972,731
General and administrative 35,081,922 24,865,942
Total operating expenses 125,703,492 60,838,673
Loss from operations (125,703,492) (60,838,673)
Other income (expenses):    
Interest/investment income, net 1,199,077 1,399,225
Realized loss on short-term investments (636,012) (156,213)
Unrealized (loss) gain on short-term investments (611,382) 139,267
Total other (expenses) income, net (48,317) 1,382,279
Net loss $ (125,751,809) $ (59,456,394)
Net loss per common share – basic and diluted (in Dollars per share) $ (7.16) $ (3.81)
Weighted average number of common shares outstanding – basic and diluted (in Shares) 17,552,738 15,594,228